Biocon Profit
- All
- News
- Videos
-
Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
Biocon Ltd on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31, 2022
-
Biocon Declines Over 3% After Net Profit Increased 105% In March Quarter
Biocon Share Price Today: On Friday, Biocon opened on the BSE at Rs 392, touching an intra day high of Rs 392 and an intra day low of Rs 380.55, in the trading session so far.
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Stocks To Watch: State Bank, Biocon, HCL Technologies
The country's largest lender State Bank of India, on Thursday said that its net profit in quarter ended December 2020 fell 7 per cent annually to Rs 5,196 crore
-
Biocon Shares Fall After Profit Declines In December Quarter
On a standalone basis, Biocon's profit plunged 72 per cent annually to Rs 33 crore from Rs 121 crore during the same period last year.
-
Biocon Posts Rs 217 Crore Profit In December Quarter, Beats Analysts' Estimates
Profit rose to Rs 217 crore in the third quarter ended December 31, compared with a profit of Rs 91.9 crore a year earlier, the company said.
-
Biocon Reports 355 Crore Rupees Consolidated Net Profit For Q2
Net profit grew whopping on account of strong top line, including biosimilar Pegfilgrastim sales in the US and margin expansion.
-
Biocon Reports 47% Jump In June Quarter Profit, Beats Analysts' Estimates
Biocon reported a net profit of Rs 120 crore for the quarter ended June 30, as against Rs 81.3 crore for the corresponding quarter a year ago.
-
The "Lucky" Bengaluru Suburb Connection Shared By Flipkart, Infosys And Biocon
Located in 447-C, 12th main, Koramangala, the bungalow is located in a leafy lane of a residential suburb that is now inundated with scores of restaurants, restro-bars and fitness centres, according to Flipkart Stories.
-
Sensex Snaps Four-Day Winning Streak; IndiGo Shares Slump 10%
The Sensex ended 73 points lower at 35,103 while Nifty settled at 10,679, down 38 points.
-
Trading Calls: Buy Biocon, Indiabulls Housing Finance, Pidilite, Says Expert
Buy Biocon at a minor dip near 605-603 range, stop-loss 600 with targets of 614, 617/18 and 621, suggests research analyst Simi Bhaumik.
-
Biocon Gets US Regulator's Nod For Biosimilar Of Cancer Drug, Shares Up 14%
Following the announcement, shares of the company opened on a bullish note and surged 14.20 per cent to touch an early high of Rs 510 on the Bombay Stock Exchange (BSE).
-
Biocon Stock Jumps As US FDA Issues EIR
Biocon confirms that the US FDA has issued on establishment inspection report in relation to the cGMP (current Good manufacuring practice) inspection of its asceptic drug product facility
-
Biocon Jumps As Malaysian Unit Gets Clearance For Supply To Europe
Biocon's Malaysia facility was inspected by the European Medicines Agency (EMA) in April 2017.
-
Biocon Shares Fall 7% As Q1 Profit Slumps
Biocon shares opened the day on a disappointing note and further declined 6.86 per cent to Rs 371.70 on the Bombay Stock Exchange (BSE).
-
Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
Biocon Ltd on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31, 2022
-
Biocon Declines Over 3% After Net Profit Increased 105% In March Quarter
Biocon Share Price Today: On Friday, Biocon opened on the BSE at Rs 392, touching an intra day high of Rs 392 and an intra day low of Rs 380.55, in the trading session so far.
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Stocks To Watch: State Bank, Biocon, HCL Technologies
The country's largest lender State Bank of India, on Thursday said that its net profit in quarter ended December 2020 fell 7 per cent annually to Rs 5,196 crore
-
Biocon Shares Fall After Profit Declines In December Quarter
On a standalone basis, Biocon's profit plunged 72 per cent annually to Rs 33 crore from Rs 121 crore during the same period last year.
-
Biocon Posts Rs 217 Crore Profit In December Quarter, Beats Analysts' Estimates
Profit rose to Rs 217 crore in the third quarter ended December 31, compared with a profit of Rs 91.9 crore a year earlier, the company said.
-
Biocon Reports 355 Crore Rupees Consolidated Net Profit For Q2
Net profit grew whopping on account of strong top line, including biosimilar Pegfilgrastim sales in the US and margin expansion.
-
Biocon Reports 47% Jump In June Quarter Profit, Beats Analysts' Estimates
Biocon reported a net profit of Rs 120 crore for the quarter ended June 30, as against Rs 81.3 crore for the corresponding quarter a year ago.
-
The "Lucky" Bengaluru Suburb Connection Shared By Flipkart, Infosys And Biocon
Located in 447-C, 12th main, Koramangala, the bungalow is located in a leafy lane of a residential suburb that is now inundated with scores of restaurants, restro-bars and fitness centres, according to Flipkart Stories.
-
Sensex Snaps Four-Day Winning Streak; IndiGo Shares Slump 10%
The Sensex ended 73 points lower at 35,103 while Nifty settled at 10,679, down 38 points.
-
Trading Calls: Buy Biocon, Indiabulls Housing Finance, Pidilite, Says Expert
Buy Biocon at a minor dip near 605-603 range, stop-loss 600 with targets of 614, 617/18 and 621, suggests research analyst Simi Bhaumik.
-
Biocon Gets US Regulator's Nod For Biosimilar Of Cancer Drug, Shares Up 14%
Following the announcement, shares of the company opened on a bullish note and surged 14.20 per cent to touch an early high of Rs 510 on the Bombay Stock Exchange (BSE).
-
Biocon Stock Jumps As US FDA Issues EIR
Biocon confirms that the US FDA has issued on establishment inspection report in relation to the cGMP (current Good manufacuring practice) inspection of its asceptic drug product facility
-
Biocon Jumps As Malaysian Unit Gets Clearance For Supply To Europe
Biocon's Malaysia facility was inspected by the European Medicines Agency (EMA) in April 2017.
-
Biocon Shares Fall 7% As Q1 Profit Slumps
Biocon shares opened the day on a disappointing note and further declined 6.86 per cent to Rs 371.70 on the Bombay Stock Exchange (BSE).
